Efficacy and Tolerability of Low-Dose Thalidomide as First-Line Systemic Treatment of Patients with Advanced Hepatocellular Carcinoma

Thomas Yau, Pierre Chan, Hilda Wong, Kelvin K. Ng, Siu-Ho Chok, Tan-To Cheung, Vincent Lam, Richard J. Epstein, Sheung-Tat Fan, Ronnie T.P. Poon
  • Oncology, January 2007, Karger Publishers
  • DOI: 10.1159/000111709

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Professor Kenneth SH Chok